Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis
Patent
1984-08-10
1987-03-17
Moyer, Donald B.
Drug, bio-affecting and body treating compositions
Fermentate of unknown chemical structure
Having a known elemental analysis
514 2, 514565, 514588, A61K 3514, A61K 31155, A61K 3117, A61K 31195
Patent
active
046506780
ABSTRACT:
A solid fibrinogen formulation is described, which formulation contains, in addition to fibrinogen, a substance containing the urea or guanidine radical, and a process for its preparation. This formulation is used for the preparation of a fibrinogen solution which is suitable as an adhesive for human and animal tissue and as a fibrinogen concentrate for intravenous administration.
REFERENCES:
patent: 4294753 (1981-10-01), Urist
patent: 4298598 (1981-11-01), Schwarz et al.
patent: 4362567 (1982-12-01), Schwarz et al.
patent: 4377572 (1983-03-01), Schwarz et al.
patent: 4414976 (1983-11-01), Schwarz et al.
patent: 4440679 (1984-04-01), Fernandes
Burk Wolfgang
Fuhge Peter
Heimburger Norbert
Stohr Hans-Arnold
Behringwerke Aktiengesellschaft
Moyer Donald B.
Stone Jacqueline M.
LandOfFree
Readily dissolvable lyophilized fibrinogen formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Readily dissolvable lyophilized fibrinogen formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Readily dissolvable lyophilized fibrinogen formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1787799